Upsher-Smith Articles
Tentative FDA approval for Supernus' Trokendi XR
27 June 2012
Upsher-Smith signs agreement to sublicense tonabersat from Proximagen to expand its CNS portfolio
13 April 2010
Showing 1-4 of 4 articles
- 1
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
